KRAS and cancer: Whereas both oncogenes and tumor suppressors, among them mTORC1, K-RAS, and p53, are implicated in the turnover of cellular glutamine [32–34], several lncRNAs have, interestingly, been shown to affect metabolic fluxes in cancer cells.